Med Page Today
AUGUST 30, 2024
(MedPage Today) -- LONDON -- The clinical benefits of semaglutide (Wegovy) went beyond expectations in the SELECT trial, given the reductions in non-cardiovascular and infectious disease deaths observed. Among people with overweight or obesity.
Physiologically Speaking
AUGUST 30, 2024
Greetings! Welcome to the Physiology Friday newsletter. Thanks to the premium sponsor of this newsletter: FSTFUEL electrolyte supplement. FSTFUEL combines electrolytes with amino acids to help your body maintain hydration and optimal functioning during exercise or intermittent fasting, so you don't have to choose between fasting and fitness. It’s a zero-sugar electrolyte drink that tastes awesome.
Science Daily - Heart Disease
AUGUST 30, 2024
The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS trial, the cardiovascular safety of interrupting beta-blocker could not be shown in comparison with beta-blocker continuation and beta-blocker interruption did not improve quality of life.
Dr. Paddy Barrett
AUGUST 30, 2024
Most people do not know that sleep is a key factor when it comes to good cardiovascular health. Because of this, sleep is pushed to the bottom of the list of priorities for addressing cardiovascular health. In my view, this is a terrible idea. Here is why. Get Sleep Right. Get Everything Else Right. There is a multitude of factors that will determine your cardiovascular risk.
Med Page Today
AUGUST 30, 2024
(MedPage Today) -- LONDON -- Vutrisiran (Amvuttra) improved functional and disease outcomes as well as survival in transthyretin amyloidosis cardiomyopathy (ATTR-CM), according to findings from the HELIOS-B phase III trial. And the benefits.
HCPLive
AUGUST 30, 2024
These data suggest that there are a subset of individuals with complete skin clearance of their psoriasis who report residual effects of their condition.
Med Page Today
AUGUST 30, 2024
(MedPage Today) -- LONDON -- Heart attack survivors who were expected to be fine after going off their beta-blockers fared worse clinically compared with those who continued them, a randomized trial showed. After years of taking these relatively.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
The New England Journal of Medicine
AUGUST 30, 2024
Measurement of low-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and lipoprotein(a) predicted the 30-year cardiovascular disease risk among women enrolled in the Women’s Health Study.
HCPLive
AUGUST 30, 2024
People with the most weekend catch-up sleep had a 20% lower risk of heart disease, especially those who were sleep-deprived during the week.
The New England Journal of Medicine
AUGUST 30, 2024
Taking a long-term view of cardiovascular disease prevention is an attractive strategy since atherosclerosis begins early in life and progresses over decades. Lowering low-density lipoprotein (LDL) cholesterol levels and improving lifestyle habits are mainstay strategies for reducing the risk of cardiovascular disease.1 Moreover, emerging therapeutic targets include vascular.
HCPLive
AUGUST 30, 2024
Researchers identified 2 genes associated with increased risk and 3 associated with decreased risk.
Becker's Hospital Review - Cardiology
AUGUST 30, 2024
Fort Myers, Fla.-based Lee Health completed its first fully endoscopic heart-valve surgery through the smallest incision possible — putting it on the forefront of cardiac care, it said in an Aug. 29 news release.
Cardiovascular Diabetology
AUGUST 30, 2024
Heart failure with preserved ejection fraction (HFpEF) is common in type 2 diabetes mellitus (T2D), leading to high morbidity and mortality. Managing HFpEF in diabetic patients is challenging with limited trea.
HCPLive
AUGUST 30, 2024
Sara Diaz Savaria, MD, discusses a study from ESC Congress 2024 examining the utility of cancer history in women as a predictor of subclinical atherosclerosis.
Society of Thoracic Surgeons - Early Career
AUGUST 30, 2024
During the 2024 STS Boot Camp in Chicago, 60 first-year cardiothoracic CT surgery residents learned from leading CT surgeons from across the country, who provided expert instruction as they gained practical experience by simulating real-world cases and emergency scenarios.
Cardiovascular Diabetology
AUGUST 30, 2024
The association between baseline triglyceride glucose index (TyG index) and incident non-communicable diseases, mainly in Asian populations, has been reported. In the current study, we aimed to evaluate the as.
Cardiometabolic Health Congress
AUGUST 30, 2024
Cardiometabolic diseases, encompassing cardiovascular conditions and metabolic disorders like diabetes, are among the most widespread global health challenges. These conditions often intersect, sharing common risk factors and underlying mechanisms. Effectively addressing them requires comprehensive, evidenced based cardiometabolic care that integrates the latest research into clinical practice.
Cardiovascular Diabetology
AUGUST 30, 2024
Continuous glucose monitoring (CGM) devices provide detailed information on daily glucose control and glycemic variability. Yet limited population-based studies have explored the association between CGM metric.
AMS Cardiology
AUGUST 30, 2024
Regular cardio exercise is one of the best ways to keep your heart strong and healthy; it helps improve blood flow and boosts your energy levels. But with so much information out there, it can be overwhelming to know where to start. Below our experts will walk you through creating a cardio workout that’s right for you, especially if you’re concerned about your heart health.
Open Heart
AUGUST 30, 2024
Background Studies comparing the safety of orexin receptor antagonists and other hypnotic types for older patients with heart failure (HF) remain lacking. This study aimed to compare orexin receptor antagonists (suvorexant) with benzodiazepines or Z-drugs for sleep treatment and investigate the risk of acute HF-related rehospitalisation in older patients with HF.
Med Page Today
AUGUST 30, 2024
(MedPage Today) -- LONDON -- Heart attack survivors who were expected to be fine after going off their beta-blockers fared worse clinically compared with those who continued them, a randomized trial showed. After years of taking these relatively.
MIBHS
AUGUST 30, 2024
In our fast-paced world, stress has become an unwelcome companion, silently taking a toll on our heart health. Fortunately, ancient practices like yoga and meditation, along with other stress-reduction techniques, offer powerful tools to combat stress and nurture our cardiovascular system. This blog explores how these practices can significantly contribute to heart health and overall well-being.
HCPLive
AUGUST 30, 2024
The STOP-or-NOT trial found similar outcomes for continuation or discontinuation of RAS inhibitors before noncardiac surgery, supporting individualized decision-making.
American College of Cardiology
AUGUST 30, 2024
A continuation strategy of renin-angiotensin system inhibitors (RASIs) before major noncardiac surgery was associated with better post-operative outcomes than discontinuation, based on results from the Stop-or-Not trial.
HCPLive
AUGUST 30, 2024
HELIOS-B trial shows vutrisiran reduces all-cause mortality and CV events in ATTR-CM, with benefits consistent regardless of tafamidis use.
Cardiovascular Diabetology
AUGUST 30, 2024
Diabetes mellitus (DM), prediabetes, and insulin resistance are highly prevalent in patients with ischemic stroke (IS).
HCPLive
AUGUST 30, 2024
The ABYSS trial suggests no clear benefit of continuing beta-blockers post-MI in patients with preserved LVEF, echoing REDUCE-AMI findings.
American College of Cardiology
AUGUST 30, 2024
The goal of the ABYSS trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction (MI).
HCPLive
AUGUST 30, 2024
Investigators identified 6 themes during semistructed interviews that contributed to and described the experience of people with gout.
American College of Cardiology
AUGUST 30, 2024
The goal of the Stop-or-Not trial was to evaluate discontinuation of renin-angiotensin system inhibitors compared with continuation before major noncardiac surgery.
HCPLive
AUGUST 30, 2024
These Mendelian analysis results highlight an association between alopecia areata and asthma, indicating a mediating role of IL-33.
American College of Cardiology
AUGUST 30, 2024
The goal of the HELIOS-B trial was to evaluate vutrisiran compared with placebo among patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).
HCPLive
AUGUST 30, 2024
Deepak Bhatt, MD, MPH, MBA, discusses common pitfalls for clinicians when interpreting trial data based on a presentation he led at ESC Congress 2024.
Circulation: Arrhythmia and Electrophysiology
AUGUST 30, 2024
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Increased mitochondrial Ca2+uptake has been implicated in the QT prolongation and lethal arrhythmias associated with nonischemic cardiomyopathy. We attempted to define the role of mitochondria in ischemic arrhythmic risk and to identify upstream regulators.METHODS:Myocardial infarction (MI) was induced in wild-type FVB/NJ mice by ligation of the left anterior descending coronary artery.
HCPLive
AUGUST 30, 2024
Experts on iron deficiency anemia discuss practical tools they utilize for the clinical administration of intravenous iron.
American College of Cardiology
AUGUST 30, 2024
The 2024 Legislative Conference taking place Sept. 29 to Oct. 1 in Washington, DC, presents a unique opportunity for ACC members to learn more about health policy, network with colleagues and speak directly with lawmakers on Capitol Hill about some of the most pressing issues facing clinicians, patients and the profession.
HCPLive
AUGUST 30, 2024
Steven Fein, MD, MPH, shares insights on the management of infusion reactions seen in patients receiving intravenous iron.
Expert insights. Personalized for you.
143 
Let's personalize your content